NICE has begun welcoming longer-term real-world outcomes (via managed access) to reassess cost-effectiveness post-launch
We commend 9amHealth for recognizing the powerful role of nutritious food and convenient delivery in engaging members and encouraging the adoption of lasting dietary and behavioral changes that support overall health, whether as part of a lifestyle shift or to complement medications like GLP-1s." Sources Mark Cuban Cost Plus Drug Company, PBC and 9amHealth Join Forces to Expand Access to Affordable Obesity Care
This product is not intended for human administration or therapeutic application
This can be performed on one or both legs, depending on your symptoms
Li M, Hao B, Zhang M, Reiter RJ, Lin S, Zheng T, et al
Semaglutide, the original weekly GLP-1 agonist, now spans injectable and oral forms and carries approvals that reach into cardiovascular risk reduction and liver disease